LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 307

Search options

  1. Article ; Online: Künstliche Intelligenz in der Pathologie – wie, wo und warum?

    Schüffler, Peter / Steiger, Katja / Mogler, Carolin

    Pathologie (Heidelberg, Germany)

    2024  Volume 45, Issue 3, Page(s) 198–202

    Abstract: Artificial intelligence promises many innovations and simplifications in pathology, but also raises just as many questions and uncertainties. In this article, we provide a brief overview of the current status, the goals already achieved by existing ... ...

    Title translation Artificial intelligence for pathology-how, where, and why?
    Abstract Artificial intelligence promises many innovations and simplifications in pathology, but also raises just as many questions and uncertainties. In this article, we provide a brief overview of the current status, the goals already achieved by existing algorithms, and the remaining challenges.
    MeSH term(s) Artificial Intelligence ; Humans ; Pathology/methods ; Pathology/trends ; Algorithms
    Language German
    Publishing date 2024-03-12
    Publishing country Germany
    Document type English Abstract ; Journal Article ; Review
    ISSN 2731-7196
    ISSN (online) 2731-7196
    DOI 10.1007/s00292-024-01314-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Vergleichende Pathologie in der onkologischen Forschung.

    Groll, Tanja / Aupperle-Lellbach, Heike / Mogler, Carolin / Steiger, Katja

    Pathologie (Heidelberg, Germany)

    2024  Volume 45, Issue 3, Page(s) 190–197

    Abstract: Comparative experimental pathology is a research field at the interface of human and veterinary medicine. It is focused on the comparative study of similarities and differences between spontaneous and experimentally induced diseases in animals (animal ... ...

    Title translation Comparative pathology in oncology-Best practice.
    Abstract Comparative experimental pathology is a research field at the interface of human and veterinary medicine. It is focused on the comparative study of similarities and differences between spontaneous and experimentally induced diseases in animals (animal models) compared to human diseases. The use of animal models for studying human diseases is an essential component of biomedical research. Interdisciplinary teams with species-specific expertise should collaborate wherever possible and maintain close communication. Mutual openness, cooperation, and willingness to learn form the basis for a fruitful collaboration. Research projects jointly led by or involving both animal and human pathologists make a significant contribution to high-quality biomedical research. Such approaches are promising not only in oncological research, as outlined in this article, but also in other research areas where animal models are regularly used, such as infectiology, neurology, and developmental biology.
    MeSH term(s) Animals ; Humans ; Neoplasms/pathology ; Disease Models, Animal ; Medical Oncology/methods ; Biomedical Research ; Pathology
    Language German
    Publishing date 2024-04-11
    Publishing country Germany
    Document type English Abstract ; Journal Article ; Review
    ISSN 2731-7196
    ISSN (online) 2731-7196
    DOI 10.1007/s00292-024-01327-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: How to use AI in pathology.

    Schüffler, Peter / Steiger, Katja / Weichert, Wilko

    Genes, chromosomes & cancer

    2023  Volume 62, Issue 9, Page(s) 564–567

    Abstract: AI plays an important role in pathology, both in clinical practice supporting pathologists in their daily work, and in research discovering novel biomarkers for improved patient care. Still, AI is in its starting phase, and many pathology labs still need ...

    Abstract AI plays an important role in pathology, both in clinical practice supporting pathologists in their daily work, and in research discovering novel biomarkers for improved patient care. Still, AI is in its starting phase, and many pathology labs still need to transition to a digital workflow to be able to enjoy the benefits of AI. In this perspective, we explain the major benefits of AI in pathology, highlight key requirements that need to be met and example how to use it in a typical workflow.
    MeSH term(s) Humans ; Workflow ; Artificial Intelligence ; Pathology/methods
    Language English
    Publishing date 2023-05-31
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1018988-9
    ISSN 1098-2264 ; 1045-2257
    ISSN (online) 1098-2264
    ISSN 1045-2257
    DOI 10.1002/gcc.23178
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Sensitive Positron Emission Tomography Imaging of PD-L1 Expression in Human Breast and Lung Carcinoma Xenografts Using the Radiometalated Peptide Ga-68-TRAP-WL12.

    Quigley, Neil Gerard / Steiger, Katja / Färber, Stefanie Felicitas / Richter, Frauke / Weichert, Wilko / Notni, Johannes

    Molecular pharmaceutics

    2024  Volume 21, Issue 4, Page(s) 1827–1837

    Abstract: Noninvasive imaging of the immune checkpoint protein programmed death ligand 1 (PD-L1; synonyms: CD274, B7-H1) holds great promise to improve patient selection and, thus, response rates for immune checkpoint therapy (ICT) with monoclonal antibodies ... ...

    Abstract Noninvasive imaging of the immune checkpoint protein programmed death ligand 1 (PD-L1; synonyms: CD274, B7-H1) holds great promise to improve patient selection and, thus, response rates for immune checkpoint therapy (ICT) with monoclonal antibodies targeting the PD1/PD-L1 axis. The PD-L1 specific peptide WL12 (cyclo(AcY-(
    MeSH term(s) Humans ; Animals ; Mice ; Gallium Radioisotopes/chemistry ; B7-H1 Antigen/metabolism ; Heterografts ; Tissue Distribution ; Peptides/chemistry ; Lung Neoplasms/diagnostic imaging ; Cell Line, Tumor ; Adenocarcinoma of Lung ; Positron-Emission Tomography/methods ; Lung/metabolism
    Chemical Substances Gallium-68 (98B30EPP5S) ; Gallium Radioisotopes ; B7-H1 Antigen ; Peptides
    Language English
    Publishing date 2024-01-31
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2138405-8
    ISSN 1543-8392 ; 1543-8384
    ISSN (online) 1543-8392
    ISSN 1543-8384
    DOI 10.1021/acs.molpharmaceut.3c01128
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Comparison of assessment of programmed death-ligand 1 (PD-L1) status in triple-negative breast cancer biopsies and surgical specimens.

    Noske, Aurelia / Steiger, Katja / Ballke, Simone / Kiechle, Marion / Oettler, Dirk / Roth, Wilfried / Weichert, Wilko

    Journal of clinical pathology

    2024  Volume 77, Issue 4, Page(s) 239–245

    Abstract: Aims: Programmed death-ligand 1 (PD-L1) status in triple-negative breast cancer (TNBC) is important for immune checkpoint inhibitor therapies but may vary between different immunohistochemical assays, scorings and the type of specimen used for analysis.! ...

    Abstract Aims: Programmed death-ligand 1 (PD-L1) status in triple-negative breast cancer (TNBC) is important for immune checkpoint inhibitor therapies but may vary between different immunohistochemical assays, scorings and the type of specimen used for analysis.
    Methods: We compared the analytical concordance of three clinically relevant PD-L1 assays (VENTANA SP142, VENTANA SP263 and DAKO 22C3 pharmDx) assessing immune cell score (IC), tumour proportion score and combined positive score (CPS) in preoperative biopsies and resection specimens of primary TNBC. PD-L1 expression was scored on virtual whole slide images and compared with expression data from corresponding surgical specimens.
    Results: The mean PD-L1 positivity in TNBC biopsies defined as IC ≥1% and CPS ≥1 ranged between 11% and 61% with the lowest positivity for SP142 and highest for SP263. The corresponding surgical specimens showed overall higher positivity rates (53%-75%). When comparing biopsies with surgical specimens, the agreement for PD-L1 positivity with SP263 and 22C3 at IC score ≥1% and CPS ≥1 was fair (kappa 0.47-0.52) and poor for SP142 (kappa 0.15-0.19). Using CPS ≥10 cut-off, the agreement for SP263 was excellent (kappa 0.751) but poor for 22C3 (kappa 0.261). Spearman correlation coefficients ranged between 0.489 and 0.75 indicating a generally moderate to strong correlation between biopsies and surgical specimens for all assays and scores.
    Conclusions: We demonstrate high accordance between biopsies and surgical specimens for SP263 and 22C3 scoring but less for SP142. Generally, biopsies are suitable for PD-L1 testing in TNBC but the appropriate assay, scoring and cut-off must be considered.
    MeSH term(s) Humans ; B7-H1 Antigen/analysis ; Biomarkers, Tumor/analysis ; Biopsy ; Immunohistochemistry ; Ligands ; Lung Neoplasms/pathology ; Triple Negative Breast Neoplasms/surgery
    Chemical Substances B7-H1 Antigen ; Biomarkers, Tumor ; Ligands
    Language English
    Publishing date 2024-03-20
    Publishing country England
    Document type Comparative Study ; Journal Article
    ZDB-ID 80261-x
    ISSN 1472-4146 ; 0021-9746
    ISSN (online) 1472-4146
    ISSN 0021-9746
    DOI 10.1136/jcp-2022-208637
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: A critical role for Akt1 signaling in acute pancreatitis progression

    Sarker, Rim Sj / Steiger, Katja

    The Journal of pathology

    2020  Volume 251, Issue 1, Page(s) 1–3

    Abstract: Acute pancreatitis (AP) is an inflammatory disease of the pancreas that causes significant morbidity and mortality worldwide. Unfortunately, there is no specific treatment available to date. Several studies have previously shown that inhibitors of the ... ...

    Abstract Acute pancreatitis (AP) is an inflammatory disease of the pancreas that causes significant morbidity and mortality worldwide. Unfortunately, there is no specific treatment available to date. Several studies have previously shown that inhibitors of the PI3K/Akt axis downregulate the degree of inflammation in animal models of AP. However, studies on in vivo side-effects of such inhibitors are still lacking. In a recent issue of The Journal of Pathology, Chen, Malagola et al investigated if inhibition of Akt signaling plays a negative role in the regenerative phase of AP. They showed that treating AP mice with an Akt inhibitor (MK2206) impaired acinar regeneration and increased the development of acinar-to-ductal metaplasia. This is the first study to highlight the negative impact of an Akt inhibitor on cellular regeneration while simultaneously inhibiting inflammation in AP. The authors also suggested combining Akt activators to recover pancreatic regeneration. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
    MeSH term(s) Acute Disease ; Animals ; Humans ; Pancreas/metabolism ; Pancreas/pathology ; Pancreatic Neoplasms/metabolism ; Pancreatic Neoplasms/pathology ; Pancreatitis/metabolism ; Pancreatitis/pathology ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction/physiology
    Chemical Substances Proto-Oncogene Proteins c-akt (EC 2.7.11.1)
    Language English
    Publishing date 2020-02-25
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 3119-7
    ISSN 1096-9896 ; 0022-3417
    ISSN (online) 1096-9896
    ISSN 0022-3417
    DOI 10.1002/path.5391
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Digitalisierung der histopathologischen Routinediagnostik : Dos and Don’ts!

    Iwuajoku, Viola / Haas, Anette / Ekici, Kübra / Khan, Mohammad Zaid / Stögbauer, Fabian / Steiger, Katja / Mogler, Carolin / Schüffler, Peter J

    Pathologie (Heidelberg, Germany)

    2024  Volume 45, Issue 2, Page(s) 98–105

    Abstract: The implementation of digital histopathology in the laboratory marks a crucial milestone in the overall digital transformation of pathology. This shift offers a range of new possibilities, including access to extensive datasets for AI-assisted analyses, ... ...

    Title translation Digital transformation of a routine histopathology lab : Dos and don'ts!
    Abstract The implementation of digital histopathology in the laboratory marks a crucial milestone in the overall digital transformation of pathology. This shift offers a range of new possibilities, including access to extensive datasets for AI-assisted analyses, the flexibility of remote work and home office arrangements for specialists, and the expedited and simplified sharing of images and data for research, conferences, and tumor boards. However, the transition to a fully digital workflow involves significant technological and personnel-related efforts. It necessitates careful and adaptable change management to minimize disruptions, particularly in the personnel domain, and to prevent the loss of valuable potential from employees who may be resistant to change. This article consolidates our institute's experiences, highlighting technical and personnel-related challenges encountered during the transition to digital pathology. It also presents a comprehensive overview of potential difficulties at various interfaces when converting routine operations to a digital workflow.
    MeSH term(s) Workflow ; Pathology/organization & administration ; Laboratories, Clinical/organization & administration
    Language German
    Publishing date 2024-01-08
    Publishing country Germany
    Document type English Abstract ; Journal Article ; Review
    ISSN 2731-7196
    ISSN (online) 2731-7196
    DOI 10.1007/s00292-023-01291-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice.

    Morrish, Emma / Wartewig, Tim / Kratzert, Andreas / Rosenbaum, Marc / Steiger, Katja / Ruland, Jürgen

    European journal of immunology

    2023  Volume 53, Issue 3, Page(s) e2250147

    Abstract: VAV1-MYO1F is a recently identified gain-of-function fusion protein of the proto-oncogene Vav guanine nucleotide exchange factor 1 (VAV1) that is recurrently detected in T-cell non-Hodgkin's lymphoma (T-NHL) patients. However, the pathophysiological ... ...

    Abstract VAV1-MYO1F is a recently identified gain-of-function fusion protein of the proto-oncogene Vav guanine nucleotide exchange factor 1 (VAV1) that is recurrently detected in T-cell non-Hodgkin's lymphoma (T-NHL) patients. However, the pathophysiological functions of VAV1-MYO1F in lymphomagenesis are insufficiently defined. Therefore, we generated transgenic mouse models to conditionally express VAV1-MYO1F in T-cells in vivo. We demonstrate that VAV1-MYO1F triggers cell autonomous activation of T-cell signaling with an activation of the ERK, JNK, and AKT pathways. VAV1-MYO1F expression induces a T-cell activation phenotype with high surface expression of CD25, ICOS, CD44, PD-1, and decreased CD62L as well as aberrant T-cell differentiation, proliferation, and neoplastic transformation. Consequently, the VAV1-MYO1F expressing T-cells induce a malignant T lymphoproliferative disease with 100% penetrance in vivo that mimics key aspects of human peripheral T-cell lymphoma. These results demonstrate that the human T-cell oncogene VAV1-MYO1F is sufficient to trigger oncogenic T-cell signaling and neoplastic transformation, and moreover, it provides a new clinically relevant mouse model to explore the pathogenesis of and treatment concepts for human T-cell lymphoma.
    MeSH term(s) Mice ; Humans ; Animals ; Proto-Oncogene Proteins c-vav/genetics ; Proto-Oncogene Proteins c-vav/metabolism ; Lymphoma, T-Cell, Peripheral/genetics ; Signal Transduction ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell/metabolism ; Mice, Transgenic ; Oncogenes ; Myosin Type I/genetics ; Myosin Type I/metabolism
    Chemical Substances Proto-Oncogene Proteins c-vav ; Receptors, Antigen, T-Cell ; VAV1 protein, human ; MYO1F protein, human ; Myosin Type I (EC 3.6.1.-) ; Vav1 protein, mouse ; Myo1f protein, mouse
    Language English
    Publishing date 2023-02-15
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 120108-6
    ISSN 1521-4141 ; 0014-2980
    ISSN (online) 1521-4141
    ISSN 0014-2980
    DOI 10.1002/eji.202250147
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Quantitative bioimaging of copper in frozen liver specimens from cats using laser ablation-inductively coupled plasma-mass spectrometry

    Yamkate, Punyamanee / Funke, Sabrina / Steiger, Katja / Gold, Randi M / Lidbury, Jonathan A / Karst, Uwe / Steiner, Joerg M

    Journal of Feline Medicine and Surgery. 2023 July, v. 25, no. 7 p.1098612X231186919-

    2023  

    Abstract: The aim of this study was to assess laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) as a tool for measuring concentrations and determining accumulation of copper in frozen liver specimens from cats. Six frozen liver specimens were ...

    Abstract The aim of this study was to assess laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) as a tool for measuring concentrations and determining accumulation of copper in frozen liver specimens from cats. Six frozen liver specimens were evaluated by qualitative copper staining and quantitative flame atomic absorption spectroscopy. Tissue specimens were cryo-sectioned and quantitative bioimaging of copper was performed using LA-ICP-MS. Results were compared with those obtained using conventional methods. Of the six specimens, only one showed positive staining for copper with rhodanine. Using flame atomic absorption spectroscopy (FAAS), one specimen showed a deficient copper level (<100 µg/g dry weight), two specimens had copper within the reference interval (RI; 150–180 µg/g) and three specimens had copper concentrations above the RI. Bioimaging from LA-ICP-MS showed inhomogeneous distribution of hepatic copper. The areas with dense copper accumulation were represented as hotspots in the liver specimens. Hepatic copper quantification by LA-ICP-MS correlated well with copper quantified by FAAS (r = 0.96, P = 0.002). Our findings suggest that quantitative bioimaging by LA-ICP-MS could be used to demonstrate the distribution and concentration of copper in frozen liver specimens from cats. The distribution of copper in these specimens was inhomogeneous with dense accumulation represented as hotspots on tissue sections. A positive correlation of hepatic copper concentrations determined by LA-ICP-MS and FAAS was found. Further studies to establish an RI for hepatic copper using this technique and to further determine its clinical utility are warranted.
    Keywords atomic absorption spectrometry ; bioimaging ; cats ; copper ; liver ; medicine ; surgery ; Hepatic copper ; heavy metal ; atomic absorption spectroscopy ; copper staining ; laser ablation-inductively coupled plasma-mass spectrometry ; LA-ICP-MS ; quantitative bioimaging
    Language English
    Dates of publication 2023-07
    Publishing place SAGE Publications
    Document type Article ; Online
    ZDB-ID 2049047-1
    ISSN 1532-2750 ; 1098-612X
    ISSN (online) 1532-2750
    ISSN 1098-612X
    DOI 10.1177/1098612X231186919
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article ; Online: The limits of molecular signatures for pancreatic ductal adenocarcinoma subtyping.

    Lautizi, Manuela / Baumbach, Jan / Weichert, Wilko / Steiger, Katja / List, Markus / Pfarr, Nicole / Kacprowski, Tim

    NAR cancer

    2022  Volume 4, Issue 4, Page(s) zcac030

    Abstract: Molecular signatures have been suggested as biomarkers to classify pancreatic ductal adenocarcinoma (PDAC) into two, three, four or five subtypes. Since the robustness of existing signatures is controversial, we performed a systematic evaluation of four ... ...

    Abstract Molecular signatures have been suggested as biomarkers to classify pancreatic ductal adenocarcinoma (PDAC) into two, three, four or five subtypes. Since the robustness of existing signatures is controversial, we performed a systematic evaluation of four established signatures for PDAC stratification across nine publicly available datasets. Clustering revealed inconsistency of subtypes across independent datasets and in some cases a different number of PDAC subgroups than in the original study, casting doubt on the actual number of existing subtypes. Next, we built sixteen classification models to investigate the ability of the signatures for tumor subtype prediction. The overall classification performance ranged from ∼35% to ∼90% accuracy, suggesting instability of the signatures. Notably, permuted subtypes and random gene sets achieved very similar performance. Cellular decomposition and functional pathway enrichment analysis revealed strong tissue-specificity of the predicted classes. Our study highlights severe limitations and inconsistencies that can be attributed to technical biases in sample preparation and tumor purity, suggesting that PDAC molecular signatures do not generalize across datasets. How stromal heterogeneity and immune compartment interplay in the diverging development of PDAC is still unclear. Therefore, a more mechanistic or a cross-platform multi-omic approach seems necessary to extract more robust and clinically exploitable insights.
    Language English
    Publishing date 2022-10-17
    Publishing country England
    Document type Journal Article
    ISSN 2632-8674
    ISSN (online) 2632-8674
    DOI 10.1093/narcan/zcac030
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top